Your Location: Set Your Location
See services nearest you.
Essentia Health Menu
Home > COVID-19 (Coronavirus) Updates > COVID-19 Monoclonal Antibody Treatment > COVID-19 ACTIV-6 Clinical Research Study
ACTIV-6 is an at-home clinical study working to find safe treatments for COVID-19. The research study is testing medications that are approved for treating health conditions other than COVID-19 to see if they can help people with mild to moderate COVID-19 feel better faster and stay out of the hospital.
ACTIV-6 is a large clinical research study testing existing prescription and over-the-counter medications for adults with mild-to-moderate COVID-19 symptoms who are not sick enough to be hospitalized. The trial is funded by the National Institutes of Health (NIH).
People can participate from anywhere in the U.S, and medications are shipped at no cost. Participation involves taking the study medication and keeping track of your symptoms and how you feel over 90 days.
ACTIV-6 is studying the following medications prioritized by the National Institutes of Health. These medications have already been approved by the U.S. Food & Drug Administration for other conditions.
You may be eligible if you:
Vaccines are available, but new, more transmissible variants of the virus are emerging in the U.S. People are still getting sick, and many remain at risk for the disease.
Results from ACTIV-6 will help researchers understand how existing medications can improve symptoms and limit hospitalizations for people with mild-to-moderate COVID-19.
If you're interested in joining the ACTIV-6 study or you'd like more information.
Call Essentia Health: 866-839-4128
For more information or to join the ACTIV-6 study
Call Essentia Health: 866-839-4128Call Toll-Free: 1-833-383-1880Visit: activ6study.org